|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||
|
|||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s53D6E82E-5F37-11EF-8869-53D784CE164B&I=39IZM&T=&OP=Display&O=html&O1=15726103&O2=4100000012430162&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DMetastatic%2520Pancreatic%2520Cancer%253A%2520Current%2520Treatment%2520Options%2520for%2520Swiss%2520Patients%26rft.au%3DAlexander%2520Meisel%26rft.au%3DAlexander%2520R.%2520Siebenh%25C3%25BCner%26rft.au%3DSara%2520De%2520Dosso%26rft.au%3DThomas%2520Winder%26rft.date%3D2021-06-01%26rft.eissn%3D2673-2106%26rft.externalDBID%3DDOA%26rft.externalDocID%3Doai_doaj_org_article_2633768889ef489dbafd165df4af3e42%26rft.genre%3Darticle%26rft.issn%3D2673-2092%26rft.issue%3D2%26rft.jtitle%3DHealthbook%2520TIMES.%2520Oncology%2520Hematology%26rft.pub%3DTHE%2520HEALTHBOOK%2520COMPANY%2520LTD%26rft.volume%3D8%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,2-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,3-ROAD_DIRECTORY_OF_OPEN_ACCESS_SCHOLARLY_RESOURCES-getFullTxt-object,4-COBIB_SI_LCL-getHolding-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.468472&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15726103-s53D6E82E-5F37-11EF-8869-53D784CE164B" timestamp="2024-08-20T23:01:11Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:4100000012430162</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Metastatic Pancreatic Cancer: Current Treatment Options for Swiss Patients</jnl:atitle>
<jnl:jtitle>Healthbook TIMES. Oncology Hematology</jnl:jtitle>
<jnl:date>2021-06-01</jnl:date>
<jnl:issn>2673-2092</jnl:issn>
<jnl:volume>8</jnl:volume>
<jnl:issue>2</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2673-2106</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:1547620521c8dabd3e3d781e5bdeefafbb6463e3</ctx:identifier>
<ctx:identifier>urn:UUID:s53D6E82E-5F37-11EF-8869-53D784CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)